Bimeda has announced the UK launch of Selenate LA, for selenium deficiency in calves and adult cattle.

Bimeda's Head of Technical Services, Padraig Hyland MVB said: "The slow release product provides raised selenium levels for a full 12 month period. When injected, Selenate LA forms a reservoir under the skin and its low solubility sees an even release of selenium over a year. But it's not just the efficacy of Selenate LA that make it such a stand out product, it's the convenience too".

Bimeda says the health properties of Barium Selenate in selenium deficient herds are well documented, from prevention of white muscle disease, anoetrus and mastitis, to improved conception rates and milk yield¹.

However there are various choices for farmers when dealing with selenium deficiency.

Padraig said: "The beauty of Selenate LA is that it is one injection, once a year. You know exactly how much each cow is getting so it's very predictable. And with many farmers already time short, it makes selenium supplementation extremely straightforward and cost effective."

Selenate LA is a POM-V medicine and can be offered by veterinary surgeons based on serum levels of glutathione peroxidase from a representative sample of the herd, or as part of a herd health and fertility plan. Padraig said: "It allows vets to offer a cost-effective and licensed alternative to oral supplements, with the added piece of mind only an injection can bring.

"The long-lasting and effective levels of selenium allow injection of the dam at any time, including mid to late pregnancy, to ensure good selenium levels in the new-born calf. This also prevents those post-calving complications such as retained foetal membranes, metritis and poor calving to conception times, where selenium deficiency has been implicated".

The company confirms that there is no milk withdrawal period and a thirty one day meat withdrawal for the product. Selenate LA is administered via a subcutaneous injection from a multi-dose bottle. For further information contact Andrew Lane, Bimeda UK Sales Manager on 07917 208524.

References

1.       1987 (Taranaki, North Island)

The British Veterinary Association has expressed concern following the announcement by the University of Surrey that it is launching a new school of veterinary medicine, with the first cohort of students due to start in 2014.

Peter Jones, President of the BVA, said: "Reports of a new veterinary course at the University of Surrey will be of significant concern to our members, particularly veterinary students and recent graduates.

"We are already seeing an increasing intake of students at the existing veterinary schools. Another veterinary course will place even more graduates onto the veterinary employment market putting significant pressure on the employment prospects of individual graduates.

"It could also impact on the ability of the profession to accommodate the increasing demand for extra mural studies (EMS) placements and the ability of all schools to continue to provide high quality education and high quality teaching staff.

"The end result could be an oversupply of highly qualified veterinary surgeons carrying significant amounts of debt unable to find employment within the profession.

"New graduates are already reporting difficulties in finding their first jobs with some saying that it takes 6 to 9 months.

"Last year the veterinary profession was removed from the Home Office's shortage occupation list because it became apparent that we currently have sufficient veterinary surgeons to meet demand. Another veterinary course could tip the balance too far the other way.

"The news from the University of Surrey also illustrates that a greater oversight of the number of veterinary graduates coming onto the market is badly needed to properly plan future requirements of the veterinary profession in the UK."

At its January meeting today, RCVS Council agreed a series of proposals for the future reform of the College's governance structure which will now go to consultation with the profession and the public before being integrated into the overall recommendations for legislative reform. 

Amongst the proposals agreed by Council was to move towards an independent appointment system for Council membership to replace the current election system.

In addition, Council voted:

• for the composition of Council to be a matter for more flexible secondary legislation rather than it being fixed via primary legislation;
• to an increase in the proportion of lay members, with a decision about whether Council should adopt parity of veterinary professionals and lay members to follow the consultation,
• to reform its composition to remove the Veterinary Schools Council (VSC) appointees. Currently the VSC has three appointed Council members
• to consult with the profession and public on two options for the future composition of a 24-person RCVS Council, which would ensure this was as balanced as possible. The first option is a Council that has a slim majority of members drawn from the veterinary professions (of whom a majority would be veterinary surgeons) compared to lay members. The second option is a Council with exact parity between veterinary professionals (of whom a majority would be veterinary surgeons) and lay members. 

Council was tied on whether to separate the position of RCVS President and the Chair of RCVS Council, meaning that this will come back for decision at a later date following the consultation.

RCVS President susan paterson, said: “The unique way that RCVS Council is currently constituted with annual elections to Council is an old model of self-regulation which is no longer found in other professions including doctors, nurses, pharmacists, solicitors and social workers, among others.

“As a responsible regulator we have a duty to operate in a way that recognises modern principles of regulation, and best meets our objectives to enhance society through improved animal health and welfare by setting, upholding and advancing the educational, ethical and clinical standards for the veterinary professions.

"The College’s recommendations would see us retain self-regulation in the sense of independence from government, and maintain registrants within our governance framework, while better assuring the public that we are acting on their behalf.

“It is our firm belief that, among other things, moving to an all-appointed Council member system, whereby those who serve on Council are selected via an independent process based on their knowledge and experience to ensure input from all parts of the veterinary sector, will better serve our aims, as will having a better balance of professional and lay members.

"Of course, veterinary expertise, knowledge and experience will also remain a vital part of any future arrangements throughout our committee structure, so the veterinary voice will be as important as ever in our policy and decision-making processes.

rcvs.org.uk/who-we-are/rcvs-council/council-meetings/18-january-2024/

Further details about the consultation process will be published in due course.

Discuss here: https://www.vetsurgeon.org/f/non-clinical-questions/30878/what-do-you-think-about-the-rcvs-proposals-to-stop-council-elections-and-move-to-appointed-members-with-equal-or-almost-equal-number-of-lay-members/243481

Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.

Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides.  It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.  

The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures.  The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.

Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system.  Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs. 

Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.

Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years.  The main problem has been that it's not been licensed as a medicine.  With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical.  We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."

Howard Wilder, founder and managing director of Genitrix, added:  "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK.  It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.

We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide.  We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."

Bayer Animal Health, maker of Seresto flea and tick collars, has carried out some market research which suggests that as many as one in ten pet owners have been duped into buying counterfeit pet medicines. 

For the research, 2000 pet owners were asked whether they they had bought counterfeit pet medicines online. 31.3% said yes. They were then asked if they had reported the matter. 62.2% said they had. Finally, they were asked what the outcome of their report was. 60.9% said their purchase was confirmed as a fake, suggesting that at least one in ten pet owners - probably more - have bought fake pet medicines.

Bayer says the true number of owners affected is likely to be even higher, as a further 12% of pet owners in the survey said they believed that they may have bought fake pet medicines but had not reported it. 

The research also showed that 87% of shoppers purchased pet parasite prevention products from unaccredited sites that have been known to sell counterfeit pet medicines. Indeed since April this year, the VMD has removed over 500 veterinary medicine listings from online marketplaces.

The message to clients is that chasing the lowest price for veterinary medicines can be a false economy.

Photo: Can you tell whether this product is fake or not?

A consultation held earlier this year by the RCVS has found that both veterinary surgeons and nurses overwhelmingly think nurses should be able to perform additional tasks that are not currently permitted under Schedule 3 of the Veterinary Surgeons Act 1966.

The consultation invited members of the professions to explain how they currently understand and interpret Schedule 3 in practice, how it could be clarified and how it might be amended to bolster the veterinary nursing profession. 

11,625 people responded to the consultation, the highest number that has ever responded to an RCVS consultation. 6,873 were veterinary nurses (around 35% of the profession and including 1,665 student veterinary nurses) and 4,752 were veterinary surgeons (around 21% of the profession).

The report on the consultation, which is published today by the Institute for Employment Studies, found that 92% of veterinary nurses and 71% of veterinary surgeons think veterinary nurses should be able to undertake additional areas of work.

However, neither vets nor nurses seem to have an especially good understanding of the current scope of Schedule 3 and how it applies in practice, rating their personal understanding at 5.6 and 6.7 out of 10 respectively.

When asked what prevented the full utilisation of veterinary nurses, the majority of both vet and vet nurse respondents highlighted a lack of understanding of what tasks can be delegated under Schedule 3, with around 60% of veterinary surgeons also admitting that they are not good at delegating.

61% of veterinary nurses and 50% of veterinary surgeons thought that the RCVS gives sufficient support and advice about Schedule 3, though the relatively poor level of understanding amongst veterinary surgeons in particular suggests more needs to be done.

In corresponding comments both veterinary nurses and veterinary surgeons said they would like more clarity, especially around 'grey areas' such as the meaning of the term 'minor surgery', as well as further communication from the College about Schedule 3 and for more training for veterinary nurses to ensure they have the competence and the confidence to carry out delegated procedures.

Liz Cox, Chair of RCVS Veterinary Nurses Council, said: "Thank you to all those who responded to the consultation in such large numbers and who shared their views on this topic. The consultation grew out of the government’s suggestion that we review Schedule 3 as a means of bolstering the VN profession, and from the VN Futures project last year, when Schedule 3 was identified as an area where there could be some additional work to clarify the rules around delegation to veterinary nurses.

"There was a clear consensus that veterinary nurses could do more in their role and under Schedule 3 and so we will be feeding the findings back to the RCVS Legislation Working Party, which will be looking, in the round, at possible changes to the framework of veterinary legislation, including how it applies to veterinary nurses and other paraprofessionals.

"In terms of the understanding of Schedule 3 and how it applies in practice it is clear that we need to do some further work to clarify the rules and develop guidance to assist both veterinary nurses and veterinary surgeons in exercising their professional judgement in respect to delegation, for example, through case studies and other examples." 

Looking at the tasks currently performed by veterinary nurses, the survey found the five most commonly performed are: clinical cleaning (92%), administration of medicines by subcutaneous injection (91%), administration of medication (90%), monitoring of anaesthesia (86.5%) and administration of medicines by intramuscular injection (86%).

The consultation also found that the majority of veterinary nurses are involved in clinics aimed at educating animal owners on various different aspects of animal health and welfare. The most common include puppy/kitten care (66.5% of respondents), nutrition (65% of respondents), general check-ups (62.5% of respondents) and dental care clinics (57% of respondents).

Post-survey interviews with 10 veterinary nurses and 10 veterinary surgeons found a number of recurring themes, including: limited career paths for veterinary nurses; poor pay for VNs relative to their training and complexity of work; lack of recognition and appreciation for the VN role; enthusiasm for advanced practitioner and specialist status for VNs; and difficulty recruiting experienced VNs.

The College says the results of the consultation will now be considered by the RCVS Schedule 3 and Legislation Working Parties, which are reviewing the efficacy of the current Veterinary Surgeons Act and whether changes need to be made to bring the legislative framework for the profession up-to-date, including consideration of the part played by allied professions like veterinary nurses in the veterinary team.

The full report can be downloaded here.

Virbac has launched Multimin, a prescription only, four in one trace mineral injection to combat oxidative stress and its effects in cattle.

Oxidative stress is an imbalance of free radicals and antioxidants which can lead to cell and tissue damage, impacting the health and performance of cattle.¹ Virbac says the trace minerals in Multimin are essential structural components of antioxidant enzymes which are required to neutralise free radicals and combat oxidative stress.^2,3

Multimin, which comes in a 100ml PET bottle, contains zinc, copper, manganese and selenium. It is designed to be administered during or before periods of high demand in dairy and beef cattle, such as breeding, calving, weaning and vaccination. After injection, it reaches peak levels in the blood after 8 hours^4,5 and the liver after 24 hours.^4,5

Virbac says Multimin has been proven in 24 peer-reviewed papers and field trials of more than 6,000 cattle, and that it offers a fast, simple and accurate way to top up essential trace minerals at times of high demand, to help improve cattle health and performance.

Lynda Maris, Virbac Large Animal Product Manager said: "Trace mineral requirements are currently primarily provided through the diet and various forms of oral supplementation. However, reduced oral intake, poor absorption from the rumen and antagonism from other minerals means that during periods of high demand, even in apparently well supplemented animals, a trace mineral gap can occur between the trace minerals required for optimum health and performance versus those available."

Lynda added: "Multimin is a great addition to the Virbac Large Animal range. It represents an exciting new opportunity for vets to strengthen their herd health plans, boost practice revenue and help to further reduce antibiotic usage."

For more information, speak to your Virbac Territory Manager or visit the Virbac stand at the BCVA Congress, 17^th – 19^th October.

References

1. Celi, P. Oxidative stress in applied basic research and clinical practice (Eds.Armstrong, D., Mandelker, L. & Vajdovich, P.). Humana Press, 191–232 (2011). 
2. Hough, M. A. & Hasnain, S. S. Structure of Fully Reduced Bovine Copper Zinc Superoxide Dismutase at 1.15 Å. Structure 11, 937–946 (2003).
3. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG and Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science, 179 (4073):588–590. 
4. Pogge, D, Richter, E, Drewnoski ME, Hansen SL. Mineral concentrations of plasma and liver following injection with a trace mineral complex differ among Angus and Simmental cattle. J. Anim.Sci. 90, 2692–2698 (2012).
5. Study data on file. 

Norbrook, maker of Thyronorm, has announced the results of a survey of 200 veterinary surgeons in which 92% said that cat owners were finding it easier to treat their pet's hyperthyroidism with a liquid than a tablet.

95% of the vets surveyed by the company reported success treating cats with Thyronorm Oral Solution for Cats, while 89% expected the liquid solution to improve compliance in the management of hyperthyroidism.

93% also said they found Thyronorm gave them an easier way to offer cats a low dose, or an 'in-between' dose, as it can be titrated 'to effect' – meaning the dose of treatment can be varied more easily to suit the individual animal.

Feline hyperthyroid specialist Dr Sarah Caney said she is unsurprised by the survey results: "Treatment is complex for cats needing a low dose, or an ‘in between’ dose, as standard anti-thyroid tablets are only available in a small number of dose sizes and are not designed to be split, halved or quartered. Also, if a cat is on alternating doses, it can be difficult for carers to remember which dose is due today."

Rachel Crowe, Norbrook’s Companion Animal Senior Product Manager, said: "We are delighted that overall 99% of the 200 veterinary surgeons surveyed would recommend Thyronorm in the management of hyperthyroidism, compared to other medical options."

Thyronorm contains 5mg/ml of thiamazole (methimazole). The initial starting dose is 5mg active ingredient per day, split into two doses.

Available in 30ml and 100ml bottles, with an in-use shelf life of six months, Thyronorm is available to order from all UK veterinary wholesalers.

Researchers at the University of Bristol’s School of Veterinary Sciences have published a new paper which argues that veterinary professionals need to move away from giving advice in a paternalistic, directive, persuasive manner, and instead adopt a more collaborative, partnership-based style.

The researchers say that when veterinary surgeons give advice to clients with the aim of changing their behaviour - such as encouraging them to feed their pet differently - they often speak in a directive style, which is driven by a paternalistic-type relationship.

This, they say, reduces a client’s sense of emotional connection to their vet, whilst limiting their personal choice and self-direction in the decision-making process. This consultation method, combined with its conflict with these basic motivational drives, may contribute to why low uptake of veterinary recommendations are reported throughout the profession.

One solution could be the use of evidence-based communication approaches that have been tried and tested in the medical profession.

Alison Bard, PhD researcher at the School of Veterinary Sciences, said: "Veterinarians are working hard to connect with their clients and promote the health of animals in their care, but being a veterinarian is not just about communicating science and methodology. Communication must also inspire motivation, prompt action and boost confidence for an animal carer to put veterinary advice into practice.

"The problem our research identified is that the perceived role of the veterinarian - to provide advice and solutions – leads to a personal communication style that leaves little room for empathy or client input. This style comes at a high cost for client engagement with advice, as we know from wider research that relational interaction and active participation of clients is essential for inspiring a change in behaviour. For the typical veterinarian, this may be surprising, as the clinical accuracy and relevance of advice has traditionally (and intuitively) been the focus of advisory services."

The research team believes a shift in veterinary surgeons' perceptions of advisory consultations is needed to improve the uptake of advice.

Alison added: "As a profession, veterinarians can benefit from recognising that behaviour change is incredibly complex. Being provided with the ‘right’ advice is not always enough for clients to put veterinary recommendations into action, especially where disease management is complicated and clients have mixed feelings over treatment options. How information is communicated in these cases affects client outcomes, meaning the difference between a motivated and unmotivated client can - in fact - be shaped by the veterinarian."

The research team hopes that this study will help veterinary surgeons think differently about their consultations by encouraging them to consider how their communication may be influencing client motivation and behaviour. As a result, they hope veterinarians will think carefully before using labels like  ‘unmotivated’ or ‘resistant to advice’, and instead explore whether their clients are perhaps just in need of emotional support, personal choice or a sense of self-confidence to truly engage with veterinary recommendations.

This call for change in the veterinary profession is already underway as a result of the VetFutures project, launched in 2015. This project called for a change in veterinary consultation style: away from a hierarchical model with the veterinary surgeon as the expert passing on instruction, to a model centred on partnership to create empowered and motivated clients.

Bristol’s research will inform this focus of the VetFutures project, and this study provides further evidence about the consequences of paternalistic communication on motivation and behaviour change in veterinary clients.

Dr Kristen Reyher, Senior Lecturer in Farm Animal Science, said: "This paper is one element of an exciting research project that will help inform and support our evolving veterinary profession. I’m confident that change can be achieved with the help of ongoing research. Our interdisciplinary work is focused on whether Motivational Interviewing - an evidence-based communication method that fosters a mutualistic approach to conversations on behaviour change - can deliver the advances VetFutures imagine for our colleagues of the future.

"We look forward to providing further evidence to contribute to a professional shift that will enhance the experience and wellbeing of veterinarians, clients and the animals in their care."

Reference

1. The future of veterinary communication: Partnership or persuasion? A qualitative investigation of veterinary communication in the pursuit of client behaviour change’ by Alison M. Bard et al in PLOS ONE

The RCVS Disciplinary Committee has reprimanded Hertfordshire-based Amir Kashiv MRCVS for the inadequate care of a dog with renal failure.

Mr Kashiv first appeared before the Committee in December 2016 in relation to four charges against him regarding his inadequate treatment of a Scottish Terrier called Tanzy which was ultimately euthanased due to renal failure.

The first charge related to Mr Kashiv’s original consultation with the owner in March 2015 and his failure to investigate for renal disease; his failure to discuss with the owner investigations to assess metastatic spread; failure to discuss with the owner alternative options to surgery such as palliative care or euthanasia and failure to explain to the owner key factors with regards to the surgery he had suggested to her, including its nature and extent, the risks involved, the fact another vet would be performing the surgery, and what to expect post-operatively.

The second charge related to the fact that, having admitted the dog as an in-patient at the practice, he failed to conduct further investigations regarding her poor condition; provide any or any adequate pain relief, or fail to record the same; failed to discuss with the owner the dog’s poor prognosis and failed to discuss with the owner the option of euthanasia.

The third charge related to the fact that Mr Kashiv discharged the animal back into her owner’s care when she was not in a fit state for discharge. The fourth and final charge related to the fact that Mr Kashiv failed to keep sufficient clear, detailed and accurate clinical records for his treatment of the dog. 

At his original hearing in December 2016, the Committee found the four charges proven and also found that charges 1 to 3 amounted to serious professional misconduct. However, the Committee decided to postpone the judgement for two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to improve his clinical practice, including putting together a personal development plan, having a mentor, accepting regular practice visits and undertaking additional continuing professional development (CPD).

The resumed hearing took place on Tuesday 18 December 2018, during which the Committee heard evidence from Dr Writer-Davies MRCVS (the veterinary surgeon appointed to review Mr Kashiv’s practice and report back to the Disciplinary Committee over the two year period), Mrs Somers MRCVS, (his appointed mentor), and Mr Kashiv himself.

Dr Writer-Davies told the Committee that she had no concerns about Mr Kashiv’s abilities regarding patient safety and that, in her view, he now meets the standards of a reasonably competent veterinary surgeon. She cited the fact he had gained in confidence when communicating with clients, had undertaken a considerable amount of CPD focused on the areas of concern identified in the case, that she had observed more detailed record keeping from him and that a veterinary nurse had been appointed to assist in running Mr Kashiv’s practice.

The evidence from Mrs Somers also found that Mr Kashiv’s knowledge was in line with that expected of a reasonably competent veterinary surgeon and that she had observed a good quality of care for pets and their owners from him.

Mr Kashiv also gave evidence, which the Committee said demonstrated considerable insight into his previous conduct and a good attitude towards self-reflective practice. The Committee also felt that the testimonials provided by Mr Kashiv showed him to be a kind and caring veterinary surgeon.

Stuart Drummond, chairing the Committee and speaking on its behalf, said: "The Committee considers that, having successfully completed the undertakings, Mr Kashiv is now a safe practitioner. The last two years has allowed Mr Kashiv to develop his skills particularly in the area of communication.

"However, the Committee has not lost sight of the fact that this was a serious case and that there was substantial harm caused to Tanzy.

"The Committee considers that in the intervening two years Mr Kashiv has gained considerable insight, developed better communication skills and remains open to improving his practice. It therefore imposes a reprimand on Mr Kashiv. The Committee considers that a reprimand is the appropriate and proportionate sanction to uphold proper professional standards and to maintain public confidence in the veterinary profession."

The Pet Food Manufacturers’ Association (PFMA) has announced the results of its annual pet population survey of 8000 households¹. 

The data shows a stable population of 12m pets, as follows:

• 9 million dogs (23% households)
• 7.5million cats (16% households)
• 600,000 rabbits (1% households
• 500,000 indoor birds (1% households)
• 400,000 Guinea Pigs (1% households)
• 500,000 domestic fowl (0.3% households)
• 300,000 tortoises and turtles (0.5% households)
• 200,000 hamsters (0.5% households)
• 200,000 snakes (0.4% households)
• 200,000 lizards (0.3% households)

There were also:

• 2.7M indoor fish tanks 
• 1.3m outdoor ponds

The survey also provides an interesting point at which to note some historical trends. Whilst cats and dogs have always been the most popular pets, 50 years ago it was budgerigars that held third place. Since then, the dog population has grown 76% and the cat population has grown 63%, whilst rabbits have moved into third place. 

Nicole Paley, PFMA Deputy Chief Executive, said: "Almost half of UK households are benefitting from pet ownership and whilst cats and dogs continue to be the most popular pets, rabbits came in at third place followed by indoor birds, guinea pigs and domestic fowl.

"A key role of PFMA is to provide educational resources on how to ensure the full range of pets get the right nutrition and we really value the role of vets and vet nurses being at the front line to pass this information on.

"At PFMA we are here to support the veterinary profession and we have a series of factsheets on popular feeding topics such as ‘Do all small mammals eat the same food’ and ‘Nutrition for indoor birds. Our pet companions fill our lives with love and joy and in return, it’s important we provide the care they need. "

For more information, visit www.pfma.org.uk/statistics

References

1. 8000 UK adults were interviewed by TNS / Solus Consulting in February 2019, in face-to-face interviews.
2. pfma.org.uk/historical-pet-ownership-statistics cross checked crossed checked with a 1963 figure and growth levels vs. PFMA data in 1987 'Companion Animals in Society' published by Oxford University Press in 1988 (which quotes PFMA data, pages 11 and 12).   

Jurox (UK) Limited has launched Buprelieve (buprenorphine), licensed for use in dogs, cats and horses. 

Buprelieve is a 0.3mg/ml buprenorphine solution for injection, licensed for post-operative analgesia and to potentiate the sedative effects of other centrally-acting agents in dogs and horses. It can be administered by intramuscular or intravenous injection to dogs and cats and by intravenous injection to horses and is available in 10ml multi-dose glass vials.

Dr Rich Irvine BVSc MRCVS, veterinary services manager at Jurox (UK) Limited said: "We are delighted to be extending our range of products with the launch of Buprelieve which will provide veterinary practices with effective and economical analgesia.

"The launch of Buprelieve will be supported by our highly qualified team of veterinary surgeons who aim to deliver top quality help, advice and assistance for clinics wishing to perform best practice anaesthesia across all patient groups."

Jurox says it has been listening to the concerns of veterinary surgeons who say they want high quality generic medicines at affordable prices along with transparency as to what they are paying for each vial. As a result, the company says it is launching Buprelieve at a very affordable list price with a simple and generous introductory offer or rebate. 

Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Jurox prides itself on providing customers with a range of high quality medicines and we believe the launch of Buprelieve will also satisfy vets’ increasing requests for competitively priced products. We understand that providing high quality pain relief is critical and Buprelieve helps vets deliver the care they demand for their patients."

For more information, contact your local Jurox technical advisor, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.